Modular response payloads for an integrated robotics platform
MARDE response payload planning now centers on outdoor AED and tourniquet delivery. Ground would have a dedicated AED bay and a reloadable tourniquet magazine, with protected low-height dispensing after operator approval. Initial demonstrations will use a training AED and packaged training kits. Direct robotic treatment, including CPR and AED electrode placement, is outside V1 and remains a longer-term research ambition.
MARDE Inc. is a Delaware C-Corporation based in New Jersey, with an initial institutional focus on New Jersey and the Northeast United States. It is pre-seed, pre-prototype and pre-revenue. There are no deployed systems, commercial pilots or validated full-system performance results. The next milestone is an integrated, human-in-the-loop V1 demonstration. This page describes development objectives, not an available emergency-response service.
Where it fits in the intended response
The proposed demonstration sequence is simulated dispatch, Nexus review, Air transport, controlled hover lowering, outdoor Ground approach, human-authorized supply dispensing and a simulated EMS handoff. Authorized retreat and pickup by a landed Air platform complete the recovery concept. This is not an existing dispatch integration. Each transition needs a responsible person, a known system state and a way to stop when assumptions no longer hold.
Payload delivery does not establish patient benefit by itself. Someone must locate the payload, understand its intended use and complete an appropriate handoff. Access, packaging and communication therefore belong in the evaluation, alongside transport. The proposed modular approach should preserve clear boundaries between robot operation, equipment use and professional clinical judgment.
Human oversight comes first
V1 is intended to remain human-in-the-loop. Consequential actions require operator authorization, and the overall system is intended to complement EMS rather than replace clinicians or responders. Higher autonomy is a possible future direction that depends on measured reliability and appropriate evaluation. A concept drawing or interface illustration does not establish safe operation.
Requirements conversations should distinguish who operates the system, who accepts the payload and who makes clinical decisions. These responsibilities may involve different people. The proposed workflow needs explicit boundaries and a practical fallback when the mission cannot continue. An emergency-response concept must remain useful to professionals even when the robotic component is unavailable.
Open engineering questions
The first engineering gates are package dimensions, Ground mass and separate bench tests of both dispensers. Tests need to measure release reliability, item condition, low-height placement, inventory confirmation and jam handling. Kit counts, exact equipment models, interfaces and total payload mass remain open. No compatibility list, medical performance or dispensing reliability has been validated.
Testing needs to connect the subsystem to the rest of the architecture. A component can succeed in isolation while the combined workflow fails because of timing, packaging, communications or a confusing handoff. MARDE's immediate goal is to investigate those interactions in a controlled integrated demonstration before making claims about operational use.
Evidence needed before evaluation
Module evaluation should document retention during movement, condition after transport, identification accuracy, accessibility and the receiving person's understanding. Any future clinical capability requires evidence beyond a robotics demonstration. Published drone-AED work helps frame questions about delivery and retrieval, but it is evidence about another system and setting, not validation of a MARDE module.
Agency evaluation should start with a written use case and success criteria agreed before testing. Records should distinguish design targets, bench observations, integrated exercises and operational outcomes. Changing a configuration or setting can invalidate a previous result. Published evidence should therefore describe limitations, exclusions and the circumstances under which a conclusion applies.
Discuss requirements with MARDE
MARDE welcomes institutional conversations with EMS agencies, fire departments, municipalities, researchers and public-safety teams. Useful input includes access barriers, operator responsibilities, dispatch constraints and acceptable evaluation conditions. The initial regional focus is New Jersey and the Northeast United States; this describes research interest, not service coverage.
Use the Contact page to discuss requirements or future evaluation opportunities. Do not send patient records or request live emergency assistance through the website. No price, purchase offer, deployment date or pilot commitment is implied by this page. The appropriate next step is a factual discussion about what would need to be built and demonstrated.